AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-192815980/acura-king-submit-nda.html" title="Facts and information about Acura, King to submit NDA for novel abuse-deterrent pain medication.(BUSINESS)">Acura, King to submit NDA for novel abuse-deterrent pain medication.(BUSINESS)</a>
Close
Set up an RSS feed that alerts you when new articles from Alcoholism & Drug Abuse Weekly are available.
Frequently asked questions about RSS feeds
Acura, King to submit NDA for novel abuse-deterrent pain medication.(BUSINESS)
Later this year Acura Pharmaceuticals Inc. (ACUR) and King Pharmaceuticals, Inc. (KG) are expected to submit a New Drug Application to the Food and Drug Administration for its Acurox tablet, a medication for moderate to severe pain designed to curb abuse potential. RTT News reported on …
Related articles from newspapers, magazines, journals, and more
-
- Press Release: Forest Laboratories submits New Drug Application for oxycodone...
-
News wire article from: Chemical Business Newsbase
December 20, 2001
700+ words
-
- Forest Laboratories receives FDA approvable letter for oxycodone HCl/ibuprofen.
-
News wire article from: Asia Africa Intelligence Wire
October 21, 2002
700+ words
-
- Statement of Purdue Pharma LP regarding FDA's approval of reformulated...
-
News wire article from: Chemical Business Newsbase
April 5, 2010
700+ words
-
- Metrics Inc Launches Generic Version of Oxycodone HCl 5mg
-
News wire article from: Europe Intelligence Wire
July 31, 2012
700+ words
-
- New Drug Application submitted for Acurox tablets.
-
News wire article from: Chemical Business Newsbase
January 2, 2009
700+ words
